A/Professor Lenka Munoz received her PharmD from Comenius University, Slovakia and her PhD in Medicinal Chemistry from the University of Bonn, Germany. Her post-doctoral training in molecular pharmacology was at the Northwestern University, Chicago, USA. Following a career disruption, she initiated her academic research career at The University of Sydney, Australia in 2011. A/Professor Munoz is Head of the Cell Signalling Laboratory at the Charles Perkins Centre and her research mainly focuses on glioblastoma, a fatal brain tumour. She uses molecular pharmacology and medicinal chemistry approaches, high-throughput omics, and hypothesis-driven strategies to interrogate glioblastoma biology, to validate new drug targets and to develop drugs acting on these targets.